Molbio and SigTuple to collaborate on the development of AI powered, battery operated, portable devices for many diagnostic tests in the fields of Hematology, Biochemistry, Electrochemistry and others
Molbio Diagnostics is collaborating with SigTuple, a medtech startup in the field of AI for diagnostics, to build next generation AI enabled portable devices for many routines but critical diagnostic tests. These devices will enable testing to be performed at the point-of-care – a doctor’s chamber, a public health centre, or an emergency room of a hospital without having to send samples to central laboratories.
Molbio and SigTuple to collaborate on the development of AI powered, battery operated, portable devices for many diagnostic tests in the fields of Hematology, Biochemistry, Electrochemistry and others. The testing process will be extremely simplified and will not require a trained laboratory technician to perform the tests. Accurate, laboratory-quality test results will be available to the patient within a few minutes.
Molbio brings in its experience in building portable point-of-care testing devices, large-scale manufacturing and sales and distribution expertise into the mix. SigTuple pitches in with its proficiency in artificial intelligence and microfluidics technologies.
Commenting on the collaboration, Sriram Natarajan, CEO, Director and Co-Founder, Molbio Diagnostics said, “Molbio started with the vision to democratise access to high quality diagnostics through innovative tools. Truenat, our point of care molecular platform, is already playing this role in the area of infectious diseases. However, there is still a gap in other critical areas. We are delighted to join with SigTuple in our Universal Access Mission and accelerate development of next gen devices that will not only fill this gap but also provide instant reports through AI to enable immediate intervention and create a positive impact on patient and societal well-being.”
Tathagato Rai Dastidar, Founder & CEO, SigTuple, said, “SigTuple started in 2015 with a singular goal – to make quality healthcare more accessible, more accurate and more affordable, with the help of AI, robotics and microfluidics. While our other products are meant for the clinical laboratories, with this new product, we will be able to push the boundaries of diagnostics much nearer to the end patient. We are truly honoured and excited to partner with Molbio, a proven leader in portable diagnostic devices, in building this product. Together, we will be able to bring this revolutionary technology into the market faster. The partnership is also a strong vote of confidence on the technological prowess of SigTuple.”